Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · IEX Real-Time Price · USD
20.77
+0.89 (4.48%)
At close: Mar 27, 2024, 4:00 PM
20.35
-0.42 (-2.02%)
After-hours: Mar 27, 2024, 6:52 PM EDT

Denali Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Denali Therapeutics stock have an average target of 48.89, with a low estimate of 28 and a high estimate of 95. The average target predicts an increase of 135.39% from the current stock price of 20.77.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $28 $48.89 $38 $95
Change +34.81% +135.39% +82.96% +357.39%

Analyst Ratings

The average analyst rating for DNLI stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 323344
Buy 787755
Hold 000000
Sell 000000
Strong Sell 000000
Total 1010101099

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Goldman Sachs
Goldman Sachs
Strong Buy
Maintains
$73$50
Strong Buy Maintains $73$50 +140.73% Feb 29, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$105$95
Strong Buy Maintains $105$95 +357.39% Feb 28, 2024
Wedbush
Wedbush
Buy
Reiterates
$31
Buy Reiterates $31 +49.25% Feb 28, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$105
Strong Buy Reiterates $105 +405.54% Feb 22, 2024
Citigroup
Citigroup
Strong Buy
Initiates
$32
Strong Buy Initiates $32 +54.07% Dec 13, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
76.15M
from 330.53M
Decreased by -76.96%
Revenue Next Year
162.84M
from 76.15M
Increased by 113.84%
EPS This Year
-2.77
from -1.06
EPS Next Year
-2.28
from -2.77
Year 2019202020212022202320242025202620272028
Revenue
26.68M335.66M48.66M108.46M330.53M76.15M162.84M226.66M423.78M683.63M
Revenue Growth
-79.34%1,158.19%-85.50%122.90%204.74%-76.96%113.84%39.19%86.97%61.32%
EPS
-2.070.63-2.39-2.60-1.06-2.77-2.28-2.30-1.690.78
EPS Growth
----------
No. Analysts -----18151055
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 283.0M 395.2M 592.3M 1.2B 1.9B
Avg 76.2M 162.8M 226.7M 423.8M 683.6M
Low n/a n/a 12.2M 9.2M 176.4M

Revenue Growth

Revenue Growth 20242025202620272028
High
-14.4%
419.0%
263.8%
427.2%
341.5%
Avg
-77.0%
113.8%
39.2%
87.0%
61.3%
Low - -
-92.5%
-95.9%
-58.4%

EPS Forecast

EPS 20242025202620272028
High -1.18 2.16 -0.26 1.85 4.87
Avg -2.77 -2.28 -2.30 -1.69 0.78
Low -3.35 -3.72 -3.89 -3.94 -2.39

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.